Ovarian Cancer
Kinase inhibition sensitizes ovarian cancer cells
Published in Women's Health Weekly, January 12th, 2006
"Signal transduction pathways associated with cancer progression and chemotherapeutic resistance are being investigated as molecular targets for chemotherapy. The P13K pathway has been found to be frequently amplified and have increased activity in ovarian cancer," wrote S.D. Westfall and colleagues, Washington State University.
"The current study investigates the efficacy of an antagonist of P13K, LY294002, in inhibiting ovarian cancer cell growth...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Bone Density
Biochemical bone markers increase during fracture repair despite low bone mineral density - Cancer Therapy
Hematologic safety and tolerability of topotecan investigated - Hormone Replacement Therapy
Action of hormone replacement therapy on insulin secretion merits further study - Myocardial Infarction
Depression is more severe in women than men after acute myocardial infarction - Radiation Therapy
Pelvic irradiation for malignancies increases risk of fracture in older women - Adipose Tissue
Alpha-linolenic acid has positive effect on heart rate variability in women - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
